Charles River Laboratories International (CRL) Gross Profit: 2009-2025
Historic Gross Profit for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $432.2 million.
- Charles River Laboratories International's Gross Profit fell 2.01% to $432.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year decrease of 17.39%. This contributed to the annual value of $1.7 billion for FY2024, which is 7.05% down from last year.
- Per Charles River Laboratories International's latest filing, its Gross Profit stood at $432.2 million for Q3 2025, which was down 3.36% from $447.3 million recorded in Q2 2025.
- Charles River Laboratories International's Gross Profit's 5-year high stood at $695.0 million during Q4 2023, with a 5-year trough of $361.8 million in Q3 2023.
- Over the past 3 years, Charles River Laboratories International's median Gross Profit value was $432.2 million (recorded in 2025), while the average stood at $438.5 million.
- As far as peak fluctuations go, Charles River Laboratories International's Gross Profit skyrocketed by 42.32% in 2021, and later crashed by 45.17% in 2024.
- Quarterly analysis of 5 years shows Charles River Laboratories International's Gross Profit stood at $437.0 million in 2021, then rose by 13.68% to $496.7 million in 2022, then surged by 39.91% to $695.0 million in 2023, then tumbled by 45.17% to $381.0 million in 2024, then decreased by 2.01% to $432.2 million in 2025.
- Its Gross Profit was $432.2 million in Q3 2025, compared to $447.3 million in Q2 2025 and $406.7 million in Q1 2025.